Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses

•Neutralizing antibody GD01 targets the Junín virus glycoprotein (GP1)•Structure of GP1 complexed with the antigen-binding fragment of GD01 was determined•GD01 binding to GP1 mimics the contacts made by the viral cellular receptor•Survivor plasma contains antibodies that target this neutralizing epitope

SummaryIn the Western hemisphere, at least five mammarenaviruses cause human viral hemorrhagic fevers with high case fatality rates. Junín virus (JUNV) is the only hemorrhagic fever virus for which transfusion of survivor immune plasma that contains neutralizing antibodies (“passive immunity”) is an established treatment. Here, we report the structure of the JUNV surface glycoprotein receptor-binding subunit (GP1) bound to a neutralizing monoclonal antibody. The antibody engages the GP1 site that binds transferrin receptor 1 (TfR1)—the host cell surface receptor for all New World hemorrhagic fever mammarenaviruses—and mimics an important receptor contact. We show that survivor immune plasma contains antibodies that bind the same epitope. We propose that viral receptor-binding site accessibility explains the success of passive immunity against JUNV and that this functionally conserved epitope is a potential target for therapeutics and vaccines to limit infection by all New World hemorrhagic fever mammarenaviruses.

Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (223 K)Download as PowerPoint slide